LCN2 and acute kidney injury: The following novel biomarkers have been identified for the early detection of AKI: cystatin C, neutrophil gelatinase-associated lipocalin, kidney injury molecule 1, liver type fatty-acid binding protein, urine angiotensinogen (AGT), and calprotectin.